Insider Trading June 5, 2026 09:04 PM

ACM Research Executive Executes Pre-Planned Stock Sales Amid Earnings Beat and Capital Raise

SVP Sotheara Cheav offloads $1.59M in shares via 10b5-1 plan as company navigates post-earnings dynamics and registered direct offering

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
ACMR

Sotheara Cheav, Senior Vice President of Manufacturing at ACM Research (Shanghai), Inc., executed a series of stock transactions totaling approximately $1.59 million in sales and $260,437 in option exercises over June 4 and 5, 2026. These actions, conducted under a Rule 10b5-1 trading plan established in March 2026, occurred against a backdrop of strong first-quarter financial results for ACM Research, Inc. (NASDAQ:ACMR) and a concurrent registered direct offering. The insider activity coincides with a recent pullback in ACMR's stock price following a significant annual return, highlighting the interplay between executive liquidity events, corporate capital strategies, and market valuation perceptions in the semiconductor equipment sector.

ACM Research Executive Executes Pre-Planned Stock Sales Amid Earnings Beat and Capital Raise
ACMR
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • ACM Research SVP Sotheara Cheav sold 18,750 shares totaling $1.59M and exercised options for 18,750 shares at $13.89/share under a Rule 10b5-1 plan established in March 2026.
  • The company reported Q1 2026 earnings of $0.34 EPS and $231.3M revenue, beating forecasts, while simultaneously announcing a registered direct offering of 2.9M shares at $52.00/share.
  • ACMR stock has seen a 209% annual return but recently pulled back to $76.29, with analysis suggesting it is overvalued relative to Fair Value.

Sotheara Cheav, serving as Senior Vice President of Manufacturing for ACM Research (Shanghai), Inc., a subsidiary of ACM Research, Inc. (NASDAQ:ACMR), has executed a significant series of equity transactions. According to a recent filing with the U.S. Securities and Exchange Commission, Cheav sold shares valued at approximately $1.59 million and exercised stock options worth roughly $260,437. These activities took place on June 4 and 5, 2026, marking a notable liquidity event for the executive.

The sales involved a total of 18,750 shares of Class A Common Stock. The transactions were executed at prices ranging between $81.73 and $85.77 per share. Crucially, these sales were carried out under a Rule 10b5-1 trading plan. Cheav adopted this pre-arranged trading framework on March 5, 2026, which allows for the execution of trades at predetermined times regardless of subsequent market movements or non-public information.

Concurrently with the sales, Cheav exercised stock options for an identical number of shares, totaling 18,750 shares of Class A Common Stock. The exercise price for these options was $13.89 per share. The filing confirms that these options were fully vested and exercisable at the time of the transactions, indicating that the executive had met all necessary criteria to convert these options into common stock.

This insider activity unfolds against a complex backdrop for ACM Research. The company recently reported first-quarter 2026 earnings that surpassed market expectations. Earnings per share came in at $0.34, exceeding the forecasted $0.28. Revenue also outperformed projections, reaching $231.3 million against an anticipated $217.77 million. Despite these positive financial results, ACM Research announced a registered direct offering of 2.9 million shares of Class A common stock. This offering is priced at $52.00 per share and is structured under a Securities Purchase Agreement with U.S. institutional investors managed by Tekne Capital Management, LLC. The offering is expected to close soon, pending customary closing conditions, which introduces potential dilution dynamics for existing shareholders.

Market performance data indicates that ACMR shares have delivered a remarkable 209% return over the past year. However, the stock has recently pulled back to $76.29. According to InvestingPro analysis, the stock currently appears overvalued relative to its Fair Value. For deeper insights into ACMR’s valuation and comprehensive analysis, investors can access the detailed Pro Research Report, available for this and 1,400+ other US equities.

In parallel developments, ACM Research’s subsidiary, ACM Research (Shanghai), Inc., filed a Record of May 2026 Investor Relations Activity with the Shanghai Stock Exchange. This filing aligns with the rules of the STAR Market, where ACM Shanghai shares are listed. An unofficial English translation of the document was also submitted to the U.S. Securities and Exchange Commission. These recent developments highlight significant activities within ACM Research, including financial performance and strategic share offerings.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.See the trade on ACMR, but can't pull the trigger?Most traders can read a chart. The hard part is the moment: entry window open, pattern forming, and you're still waiting for more confirmation. That's the conviction gap — and our chart analysis closes it. Unlike other AIs that just read data, our Vision AI literally "sees" your charts and hands you a complete trading plan: entry, stop-loss, and profit target in under 60 seconds. Know exactly what to do next, every time.Try Chart Analysis for ACMR

Risks

  • The registered direct offering of 2.9 million shares introduces potential dilution for existing shareholders as the offering closes pending customary conditions.
  • Recent stock pullback to $76.29 from higher levels, combined with analysis indicating overvaluation relative to Fair Value, suggests potential downside risk for investors.
  • The execution of insider sales under a pre-arranged plan, while standard, coincides with a period of significant corporate capital raising and valuation adjustments.

More from Insider Trading

WhiteHorse Finance Director Bolduc Acquires Nearly $100K in Company Stock Jun 5, 2026 Delek US Holdings Director Offloads Shares Amid Strong Stock Performance Jun 5, 2026 Natera CEO Executes $9.09 Million Stock Sale Under Pre-Arranged Plan Jun 5, 2026 Sitime Executive Fariborz Assaderaghi Disposes of $1.41M in Shares Amid Volatile Market Conditions Jun 5, 2026 Sitime CEO Rajesh Vashist Offloads $28 Million in Corporate Shares Jun 5, 2026